Patient demographics and immediate results of primary angioplasty in the SOLACI registry;Perfil Demográfico e Resultados Imediatos dos Pacientes Submetidos a Angioplastia Primária no Registro SOLACI

Revista Brasileira de Cardiologia Invasiva

Volumn 17, Issue 3, 2009, Pages 335-339

  Sousa, Amanda G M R ^a   Costa Jr , J Ribamar ^a   Abizaid, Alexandre ^a   Buitrón, Fausto ^b   Costantini, Costantino ^c   Marchant, Eugenio ^d   Belardi, Jorge A ^e   Nitola, Alberto Suárez ^f   Londero, Hugo F ^g   Martínez Rios, Marco ^h   Sousa, J Eduardo ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b Asociacion Espanola Primera de Socorros Mutuos   (Uruguay)

^c Hospital Cardiologico Costantini   (Brazil)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^f HOSPITAL MILITAR CENTRAL   (Colombia)

^g Sanatorio Allende   (Argentina)

^h INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Angioplasty; Latin America; Stents; Treatment outcome

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG UTILIZATION; FEMALE; HEART INFARCTION; HEART REINFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT INFORMATION; REGISTER; REVASCULARIZATION; SOUTH AND CENTRAL AMERICA; STENT; TREATMENT OUTCOME;

EID: 77951153863     PISSN: 01041843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nordmann AJ, Bucher H, Hengstler P, Harr T, Young J. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction. Cochrane Database Syst Rev. 2005;(2):CD005313.
2. Buchan I, Hooper L, McElduff P, Freemantle N, Martin D. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Lancet. 2003;361(9365):1304.
3. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278(23):2093-2098 (Pubitemid 28016233)
4. th Edition). Chest. 2008;133(6 Suppl):708S-775S. (Pubitemid 351892976)
5. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008;117(2):296-329.
6. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al.; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346(13):957-966
7. Mehta RH, Harjai KJ, Cox DA, Stone GW, Brodie BR, Boura J, et al.; Primary Angioplasty in Myocardial Infarction investigators. Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2005;96(7):901-906
8. Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J. 2004;147(5):815-822
9. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, et al. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Clin Cardiol. 2008;31(3 Suppl 1):I2-9.
10. Kashani A, Giugliano RP. Management of ST-elevation myocardial infarction: an update on pharmacoinvasive reca-nalization. Am J Cardiovasc Drugs. 2008;8(3):187-197
11. Nappi J. Benefits and limitations of current antiplatelet therapies. Am J Health Syst Pharm. 2008;65(13 Suppl 5):S5-10; quiz S16-8.
12. Montalescot G, Antoniucci D, Kastrati A, Neumann FJ, Borentain M, Migliorini A, et al. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients data with long-term follow-up. Eur Heart J. 2007;28(4):443-449
13. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005;293(14):1759-1765
14. Biondi-Zoccai GG, Abbate A, Agostoni P, Testa L, Burzotta F, Lotrionte M, et al. Long-term benefits of an early invasive management in acute coronary syndromes depend on intra-coronary stenting and aggressive antiplatelet treatment: a metaregression. Am Heart J. 2005;149(3):504-511
15. Pannu R, Andraws R. Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials. Crit Pathw Cardiol. 2008;7(1):5-10.
16. Mehilli J, Kastrati A, Schulz S, Früngel S, Nekolla SG, Moshage W, et al.; Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation. 2009; 119(14):1933-1940
17. Bakhai A, Stone GW, Grines CL, Murphy SA, Githiora L, Berezin RH, et al.; CADILLAC Investigators. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. Circulation. 2003;108(23):2857-2863